Logo Logo Logo Logo Logo
  • Home
  • About
    • Company
    • Leadership
    • Advisors
    • Partners
    • Careers
  • Technology
    • BARD1 Science
    • Scientific Rationale
    • Applications
      • Cancer Diagnostics
      • Cancer Therapeutics
    • Market Potential
    • Intellectual Property
    • Publications
  • Pipeline
    • Overview
    • BARD1-Lung test
      • Product description
      • Lung cancer facts
      • Validation Results
      • Clinical Validation
    • BARD1-Ovarian test
    • BARD1 Research
    • BARD1 Vaccine
    • Business Development
  • Investors
    • Snapshot
    • Announcements
    • Reports
    • Presentations
    • Share Information
    • Analyst Coverage
    • Corporate Governance
  • News
  • FAQ
  • Contact
  • Home

  • About

    • Company
    • Leadership
    • Advisors
    • Partners
    • Careers

  • Technology

    • BARD1 Science
    • Scientific Rationale
    • Applications
      • Cancer Diagnostics
      • Cancer Therapeutics
    • Market Potential
    • Intellectual Property
    • Publications

  • Pipeline

    • Overview
    • BARD1-Lung test
      • Product description
      • Lung cancer facts
      • Validation Results
      • Clinical Validation
    • BARD1-Ovarian test
    • BARD1 Research
    • BARD1 Vaccine
    • Business Development

  • Investors

    • Snapshot
    • Announcements
    • Reports
    • Presentations
    • Share Information
    • Analyst Coverage
    • Corporate Governance
  • News
  • FAQ
  • Contact
Contact
HEADQUARTERS ADDRESS
Harry Perkins Institute of Medical Research
L2/QQ Block, 6 Verdun St
Nedlands WA 6009
Australia

P: +61 8 9381 9550
F: +61 8 9388 7559
E: info@bard1.com

POSTAL ADDRESS
PO Box 7493
Cloisters Square
Perth WA 6850
Australia

t-social   ln-social
Copyright © 2019 BARD1. All rights reserved. 78220 acorndesign.com.au